Skip to main content
SpringerLink
Log in

Elevated Expression of CD109 in Esophageal Squamous Cell Carcinoma

  • Letter to Editor
  • Published:
Pathology & Oncology Research

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Stoner GD, Wang LS, Chen T (2007) Chemoprevention of esophageal squamous cell carcinoma. Toxicol Appl Pharmacol 224(3):337–349. doi:10.1016/j.taap.2007.01.030

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Osawa H, Nakajima M, Kato H, Fukuchi M, Kuwano H (2004) Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma. Anticancer Res 24(6):3703–3709

    CAS  PubMed  Google Scholar 

  3. Megumi K, Ishigami S, Uchikado Y, Kita Y, Okumura H, Matsumoto M, Uenosono Y, Arigami T, Kijima Y, Kitazono M, Shinchi H, Ueno S, Natsugoe S (2012) Clinicopathological significance of BMP7 expression in esophageal squamous cell carcinoma. Ann Surg Oncol 19(6):2066–2071. doi:10.1245/s10434-011-2024-5

    Article  PubMed Central  PubMed  Google Scholar 

  4. Finnson KW, Tam BY, Liu K, Marcoux A, Lepage P, Roy S, Bizet AA, Philip A (2006) Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes. FASEB J Off Publ Fed Am Soc Exp Biol 20(9):1525–1527. doi:10.1096/fj.05-5229fje

    CAS  Google Scholar 

  5. Hashimoto M, Ichihara M, Watanabe T, Kawai K, Koshikawa K, Yuasa N, Takahashi T, Yatabe Y, Murakumo Y, Zhang JM, Nimura Y, Takahashi M (2004) Expression of CD109 in human cancer. Oncogene 23(20):3716–3720. doi:10.1038/sj.onc.1207418

    Article  CAS  PubMed  Google Scholar 

  6. Ozbay PO, Ekinci T, Yigit S, Yavuzcan A, Uysal S, Soylu F, Cakalagaoglu F (2013) Investigation of prognostic significance of CD109 expression in women with vulvar squamous cell carcinoma. Onco Targets Ther 6:621–627. doi:10.2147/OTT.S41069

    PubMed Central  PubMed  Google Scholar 

  7. Zhang JM, Hashimoto M, Kawai K, Murakumo Y, Sato T, Ichihara M, Nakamura S, Takahashi M (2005) CD109 expression in squamous cell carcinoma of the uterine cervix. Pathol Int 55(4):165–169. doi:10.1111/j.1440-1827.2005.01807.x

    Article  CAS  PubMed  Google Scholar 

  8. Duff B, Weigel JA, Bourne P, Weigel PH, McGary CT (2002) Endothelium in hepatic cavernous hemangiomas does not express the hyaluronan receptor for endocytosis. Hum Pathol 33(3):265–269

    Article  PubMed  Google Scholar 

  9. Cuppini L, Calleri A, Bruzzone MG, Prodi E, Anghileri E, Pellegatta S, Mancuso P, Porrati P, Di Stefano AL, Ceroni M, Bertolini F, Finocchiaro G, Eoli M (2013) Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan. PLoS One 8(9):e74345. doi:10.1371/journal.pone.0074345

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Hagiwara S, Murakumo Y, Sato T, Shigetomi T, Mitsudo K, Tohnai I, Ueda M, Takahashi M (2008) Up-regulation of CD109 expression is associated with carcinogenesis of the squamous epithelium of the oral cavity. Cancer Sci 99(10):1916–1923. doi:10.1111/j.1349-7006.2008.00949.x

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by Shandong Taishan Scholarship (Ju Liu) from Shandong Provincial Government. Ju Liu confirms that the work was performed independence from the sponsors and the content of the article has not been influenced by the sponsors.

Author Contribution

Guarantor of the article: Ju Liu, Zhongmin Jiang

Specific author contributions:

FD, FL, YS, XL: Data collection, analysis and interpretation; drafting the manuscript; final approval of the version to be published.

ZJ, JL: project conception/initiation; experimental design; drafting of the manuscript; critical revision; final approval of the version to be published.

Conflict of interest

None

Author information

Authors and Affiliations

  1. Shandong Provincial Qianfoshan Hospital, Shandong University, 16766 Jingshi Road, Jinan, Shandong, China, 250014

    Fengyun Dong, Fuhong Liu, Suhua Yan, Zhongmin Jiang & Ju Liu

  2. Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA

    Xiaochun Liu

Authors
  1. Fengyun Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fuhong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Suhua Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiaochun Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhongmin Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ju Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Zhongmin Jiang or Ju Liu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dong, F., Liu, F., Yan, S. et al. Elevated Expression of CD109 in Esophageal Squamous Cell Carcinoma. Pathol. Oncol. Res. 21, 1273–1275 (2015). https://doi.org/10.1007/s12253-014-9894-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-014-9894-3

Keywords

Search

Navigation